Hide

FocusBar

Subscribe to Premium Member
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.166
WLP's Cash to Debt is ranked lower than
88% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.88 vs. WLP: 0.166 )
WLP' s 10-Year Cash to Debt Range
Min: 0.17   Max: 0.57
Current: 0.17

0.17
0.57
Equity to Asset -0.048
WLP's Equity to Asset is ranked lower than
76% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.20 vs. WLP: -0.048 )
WLP' s 10-Year Equity to Asset Range
Min: -0.05   Max: 0.35
Current: -0.05

-0.05
0.35
Interest Coverage 7.6
WLP's Interest Coverage is ranked higher than
76% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 265.90 vs. WLP: 7.6 )
WLP' s 10-Year Interest Coverage Range
Min: 7   Max: 18
Current: 7.6

7
18
F-Score: 4
Z-Score: 1.97
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 6.30
WLP's Operating margin (%) is ranked higher than
71% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.00 vs. WLP: 6.30 )
WLP' s 10-Year Operating margin (%) Range
Min: 5.1   Max: 11.4
Current: 6.3

5.1
11.4
Net-margin (%) 4.3
WLP's Net-margin (%) is ranked higher than
71% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.10 vs. WLP: 4.3 )
WLP' s 10-Year Net-margin (%) Range
Min: 0.4   Max: 7.3
Current: 4.3

0.4
7.3
ROE (%) 11.2
WLP's ROE (%) is ranked higher than
59% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.20 vs. WLP: 11.2 )
WLP' s 10-Year ROE (%) Range
Min: 2.7   Max: 19.1
Current: 11.2

2.7
19.1
ROA (%) 4.5
WLP's ROA (%) is ranked higher than
65% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.80 vs. WLP: 4.5 )
WLP' s 10-Year ROA (%) Range
Min: 0.9   Max: 9.1
Current: 4.5

0.9
9.1
ROC (Joel Greenblatt) (%) 6357.70
WLP's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 86.80 vs. WLP: 6357.70 )
WLP' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 669.7   Max: 6357.7
Current: 6357.7

669.7
6357.7
Revenue Growth (%) 8.9
WLP's Revenue Growth (%) is ranked higher than
88% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.35 vs. WLP: 8.9 )
WLP' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 12.9
Current: 8.9

0
12.9
EBITDA Growth (%) -2.4
WLP's EBITDA Growth (%) is ranked higher than
76% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.00 vs. WLP: -2.4 )
WLP' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 19.5
Current: -2.4

0
19.5
EPS Growth (%) -4.6
WLP's EPS Growth (%) is ranked higher than
59% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.10 vs. WLP: -4.6 )
WLP' s 10-Year EPS Growth (%) Range
Min: 0   Max: 19.7
Current: -4.6

0
19.7
» WLP's 10-Y Financials

Financials


Revenue & Net Income
Equity & Asset
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2012

WLP Guru Trades in Q2 2012

David Einhorn 1,930,689 sh (New)
Daniel Loeb 850,000 sh (New)
Steven Cohen 999,189 sh (+56.93%)
Jean-Marie Eveillard 6,762,157 sh (+21.03%)
Joel Greenblatt 11,842 sh (+7.4%)
First Pacific Advisors 2,673,400 sh (+3.99%)
Steven Romick 2,395,000 sh (+3.68%)
John Hussman 800,000 sh (unchged)
Bernard Horn 36,600 sh (unchged)
Dodge & Cox 6,000 sh (unchged)
Vanguard Health Care Fund 7,902,400 sh (unchged)
Tom Russo 204 sh (unchged)
Alan Fournier 2,827,892 sh (unchged)
George Soros Sold Out
Louis Moore Bacon Sold Out
Jeff Auxier 65,421 sh (-0.23%)
Pioneer Investments 3,467 sh (-0.86%)
Leon Cooperman 2,043,727 sh (-2.13%)
James Barrow 11,750,325 sh (-2.31%)
Jeremy Grantham 554,197 sh (-5.84%)
Paul Tudor Jones 7,900 sh (-27.52%)
Ray Dalio 10,316 sh (-88.81%)
» More
Q3 2012

WLP Guru Trades in Q3 2012

Donald Yacktman 3,518,467 sh (New)
HOTCHKIS & WILEY 1,828,100 sh (New)
Richard Snow 997,902 sh (New)
Ray Dalio 148,537 sh (+1339.87%)
Joel Greenblatt 23,595 sh (+99.25%)
Paul Tudor Jones 12,100 sh (+53.16%)
James Barrow 17,288,330 sh (+47.13%)
Daniel Loeb 1,250,000 sh (+47.06%)
Alan Fournier 3,299,892 sh (+16.69%)
First Pacific Advisors 2,674,000 sh (+0.02%)
Steven Romick 2,395,000 sh (unchged)
Yacktman Fund 1,350,000 sh (unchged)
Bernard Horn 36,600 sh (unchged)
Yacktman Focused Fund 1,600,000 sh (unchged)
Tom Russo 204 sh (unchged)
Pioneer Investments Sold Out
Vanguard Health Care Fund 7,702,400 sh (-2.53%)
Jeff Auxier 63,571 sh (-2.83%)
Jeremy Grantham 507,297 sh (-8.46%)
Jean-Marie Eveillard 6,133,756 sh (-9.29%)
Dodge & Cox 5,000 sh (-16.67%)
Leon Cooperman 1,285,527 sh (-37.1%)
John Hussman 500,000 sh (-37.5%)
David Einhorn 958,173 sh (-50.37%)
Steven Cohen 22,912 sh (-97.71%)
» More
Q4 2012

WLP Guru Trades in Q4 2012

Chris Davis 4,050 sh (New)
Steven Cohen 311,800 sh (+1260.86%)
HOTCHKIS & WILEY 4,456,671 sh (+143.79%)
James Barrow 18,130,049 sh (+4.87%)
Yacktman Fund 1,406,800 sh (+4.21%)
Donald Yacktman 3,621,535 sh (+2.93%)
Paul Tudor Jones 12,400 sh (+2.48%)
Jean-Marie Eveillard 6,189,156 sh (+0.9%)
Tom Russo 204 sh (unchged)
Yacktman Focused Fund 1,600,000 sh (unchged)
Jeremy Grantham 459,646 sh (unchged)
Vanguard Health Care Fund 7,702,400 sh (unchged)
Bernard Horn 36,600 sh (unchged)
David Einhorn Sold Out
Daniel Loeb Sold Out
Leon Cooperman 1,282,127 sh (-0.26%)
Jeff Auxier 62,771 sh (-1.26%)
Alan Fournier 3,189,292 sh (-3.35%)
Richard Snow 960,264 sh (-3.77%)
Steven Romick 2,025,000 sh (-15.45%)
First Pacific Advisors 2,260,700 sh (-15.46%)
Dodge & Cox 4,000 sh (-20%)
John Hussman 339,000 sh (-32.2%)
Ray Dalio 50,912 sh (-65.72%)
Joel Greenblatt 3,468 sh (-85.3%)
» More
Q1 2013

WLP Guru Trades in Q1 2013

Tom Gayner 50,000 sh (New)
Bruce Kovner 85,000 sh (New)
John Burbank 7,586 sh (New)
Paul Tudor Jones 330,500 sh (+2565.32%)
Chris Davis 7,880 sh (+94.57%)
Jeff Auxier 63,471 sh (+1.12%)
Jean-Marie Eveillard 6,238,556 sh (+0.8%)
Donald Yacktman 3,640,189 sh (+0.52%)
Bernard Horn 36,600 sh (unchged)
Yacktman Focused Fund 1,600,000 sh (unchged)
Tom Russo 204 sh (unchged)
Dodge & Cox 4,000 sh (unchged)
Vanguard Health Care Fund 7,702,400 sh (unchged)
Steven Romick 2,025,000 sh (unchged)
First Pacific Advisors 2,260,700 sh (unchged)
Yacktman Fund 1,406,800 sh (unchged)
John Hussman Sold Out
Ray Dalio Sold Out
Leon Cooperman Sold Out
Alan Fournier Sold Out
Joel Greenblatt Sold Out
James Barrow 17,860,497 sh (-1.49%)
Richard Snow 944,898 sh (-1.6%)
Jeremy Grantham 386,414 sh (-15.93%)
HOTCHKIS & WILEY 3,347,698 sh (-24.88%)
Steven Cohen 86,962 sh (-72.11%)
» More
» Details

Insider Trades

Latest Guru Trades with WLP

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Leon Cooperman 2013-03-31 Sold Out 1.4%$58.93 - $66.28 $ 77.8123%0
John Hussman 2013-03-31 Sold Out 0.54%$58.93 - $66.28 $ 77.8123%0
HOTCHKIS & WILEY 2013-03-31 Reduce -24.88%0.4%$58.93 - $66.28 $ 77.8123%3347698
Tom Gayner 2013-03-31 New Buy0.12%$58.93 - $66.28 $ 77.8123%50000
Ray Dalio 2013-03-31 Sold Out 0.03%$58.93 - $66.28 $ 77.8123%0
John Burbank 2013-03-31 New Buy0.02%$58.93 - $66.28 $ 77.8123%7586
Joel Greenblatt 2013-03-31 Sold Out 0.01%$58.93 - $66.28 $ 77.8123%0
Chris Davis 2013-03-31 Add 94.57%$58.93 - $66.28 $ 77.8123%7880
Daniel Loeb 2012-12-31 Sold Out 1.4%$54.33 - $63.03 $ 77.8132%0
HOTCHKIS & WILEY 2012-12-31 Add 143.79%0.94%$54.33 - $63.03 $ 77.8132%4456671
David Einhorn 2012-12-31 Sold Out 0.93%$54.33 - $63.03 $ 77.8132%0
John Hussman 2012-12-31 Reduce -32.2%0.23%$54.33 - $63.03 $ 77.8132%339000
Ray Dalio 2012-12-31 Reduce -65.72%0.08%$54.33 - $63.03 $ 77.8132%50912
Joel Greenblatt 2012-12-31 Reduce -85.3%0.08%$54.33 - $63.03 $ 77.8132%3468
Chris Davis 2012-12-31 New Buy$54.33 - $63.03 $ 77.8132%4050
Richard Snow 2012-09-30 New Buy3.2%$52.95 - $64.31 $ 77.8132%997902
Donald Yacktman 2012-09-30 New Buy1.2%$52.95 - $64.31 $ 77.8132%3518467
Leon Cooperman 2012-09-30 Reduce -37.1%1.08%$52.95 - $64.31 $ 77.8132%1285527
David Einhorn 2012-09-30 Reduce -50.37%0.96%$52.95 - $64.31 $ 77.8132%958173
James Barrow 2012-09-30 Add 47.13%0.64%$52.95 - $64.31 $ 77.8132%17288330
HOTCHKIS & WILEY 2012-09-30 New Buy0.63%$52.95 - $64.31 $ 77.8132%1828100
Daniel Loeb 2012-09-30 Add 47.06%0.45%$52.95 - $64.31 $ 77.8132%1250000
John Hussman 2012-09-30 Reduce -37.5%0.36%$52.95 - $64.31 $ 77.8132%500000
Ray Dalio 2012-09-30 Add 1339.87%0.11%$52.95 - $64.31 $ 77.8132%148537
Joel Greenblatt 2012-09-30 Add 99.25%0.05%$52.95 - $64.31 $ 77.8132%23595
David Einhorn 2012-06-30 New Buy1.9%$65.15 - $73.13 $ 77.8113%1930689
Daniel Loeb 2012-06-30 New Buy1.7%$65.15 - $73.13 $ 77.8113%850000
Jean-Marie Eveillard 2012-06-30 Add 21.03%0.3%$65.15 - $73.13 $ 77.8113%6762157
Ray Dalio 2012-06-30 Reduce -88.81%0.1%$65.15 - $73.13 $ 77.8113%10316
George Soros 2012-06-30 Sold Out 0.07%$65.15 - $73.13 $ 77.8113%0
Premium More recent guru trades are included for Premium Members only!!

Top Ranked Articles about WellPoint Inc

WellPoint (WLP) - A Comprehensive Value Analysis Daniel Loeb - WellPoint (WLP) - A Comprehensive Value Analysis
Putting Politics Aside to Make Money Read more...
Simon Properties Reports Insider Trades
In the past week two directors of Simon Property Group Inc. (SPG) have invested nearly $300,000 in SPG shares. Read more...
Donald Yacktman Finds Two Undervalued Companies in His Most Bought, In-Favor Sector of Q3 Donald Yacktman - Donald Yacktman Finds Two Undervalued Companies In His Most Bought, In-Favor Sector Of Q3
Donald Yacktman is an expert at identifying out-of-favor or undervalued sectors, buying them at the right price and ultimately profiting from their resurgence. “We use a variety of techniques to find ideas, including screens, although the best opportunities are often created because of short-term challenges within a business or its sector,” he said recently. Read more...
Donald Yacktman Buys 4 New Stocks in Q3 Donald Yacktman - Donald Yacktman Buys 4 New Stocks In Q3
Donald Yacktman of Yacktman Asset Management reported his third quarter portfolio on Monday, which his largest new buys were WellPoint Inc. (WLP), CH Robinson Worldwide (CHRW), Liberty Ventures (LVNTA) and Abbott Laboratories (ABR). Read more...
Stocks Trading for Less Than David Einhorn Paid for Them David Einhorn - Stocks Trading For Less Than David Einhorn Paid For Them
David Einhorn has achieved a 21.5% annualized return at his firm, Greenlight Capital, since he founded it in 1996, by investing in undervalued long positions and short positions. Four of his holdings are currently trading for less than he paid for them: Marvell Technology Group (MRVL), WellPoint (WLP), Humana (HUM) and Genworth Financial (GNW). Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 9.20
WLP's P/E(ttm) is ranked higher than
88% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.80 vs. WLP: 9.20 )
WLP' s 10-Year P/E(ttm) Range
Min: 4.33   Max: 36.99
Current: 9.2

4.33
36.99
P/B 0.99
WLP's P/B is ranked higher than
82% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.50 vs. WLP: 0.99 )
WLP' s 10-Year P/B Range
Min: 0.71   Max: 4.21
Current: 0.99

0.71
4.21
P/S 0.38
WLP's P/S is ranked lower than
59% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.40 vs. WLP: 0.38 )
WLP' s 10-Year P/S Range
Min: 0.26   Max: 1.33
Current: 0.38

0.26
1.33
PFCF 12.45
WLP's PFCF is ranked lower than
71% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.43 vs. WLP: 12.45 )
WLP' s 10-Year PFCF Range
Min: 5.86   Max: 50.97
Current: 12.45

5.86
50.97
EV-to-EBIT 9.85
WLP's EV-to-EBIT is ranked lower than
65% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.65 vs. WLP: 9.85 )
WLP' s 10-Year EV-to-EBIT Range
Min: 2.9   Max: 33.9
Current: 9.85

2.9
33.9
PEG 0.59
WLP's PEG is ranked higher than
71% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.80 vs. WLP: 0.59 )
WLP' s 10-Year PEG Range
Min: 0.29   Max: 1.77
Current: 0.59

0.29
1.77
Shiller P/E 10
WLP's Shiller P/E is ranked higher than
71% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.40 vs. WLP: 10 )
WLP' s 10-Year Shiller P/E Range
Min: 6.81   Max: 22.88
Current: 10

6.81
22.88

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.59
WLP's Dividend Yield is ranked higher than
88% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.40 vs. WLP: 1.59 )
WLP' s 10-Year Dividend Yield Range
Min: 0.31   Max: 2.02
Current: 1.59

0.31
2.02
Dividend Payout 0.2
WLP's Dividend Payout is ranked higher than
76% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.13 vs. WLP: 0.2 )
WLP' s 10-Year Dividend Payout Range
Min: 0.14   Max: 0.14
Current: 0.2

Yield on cost (5-Year) 1.60
WLP's Yield on cost (5-Year) is ranked higher than
71% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.55 vs. WLP: 1.60 )
WLP' s 10-Year Yield on cost (5-Year) Range
Min: 0.31   Max: 2.02
Current: 1.6

0.31
2.02
Share Buyback Rate 9.3
WLP's Share Buyback Rate is ranked higher than
94% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.70 vs. WLP: 9.3 )
WLP' s 10-Year Share Buyback Rate Range
Min: 0   Max: -26.6
Current: 9.3

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 6.7
WLP's Price/Net Current Asset Value is ranked lower than
71% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.10 vs. WLP: 6.7 )
WLP' s 10-Year Price/Net Current Asset Value Range
Min: 5.6   Max: 15.1
Current: 6.7

5.6
15.1
Price/DCF (Projected) 0.4
WLP's Price/DCF (Projected) is ranked lower than
71% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.60 vs. WLP: 0.4 )
WLP' s 10-Year Price/DCF (Projected) Range
Min: 0.3   Max: 0.9
Current: 0.4

0.3
0.9
Price/Median PS Value 0.7
WLP's Price/Median PS Value is ranked lower than
76% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.70 vs. WLP: 0.7 )
WLP' s 10-Year Price/Median PS Value Range
Min: 0.6   Max: 2.2
Current: 0.7

0.6
2.2
Price/Peter Lynch Fair Value 0.6
WLP's Price/Peter Lynch Fair Value is ranked higher than
65% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.80 vs. WLP: 0.6 )
WLP' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.5   Max: 1.1
Current: 0.6

0.5
1.1
Earnings Yield (Greenblatt) 10.20
WLP's Earnings Yield (Greenblatt) is ranked lower than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.60 vs. WLP: 10.20 )
WLP' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.9   Max: 34.7
Current: 10.2

2.9
34.7
Forward Rate of Return (Yacktman) 21.4
WLP's Forward Rate of Return (Yacktman) is ranked higher than
71% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 20.32 vs. WLP: 21.4 )
WLP' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 15.5   Max: 29.5
Current: 21.4

15.5
29.5

Business Description

WellPoint Inc is an Indiana corporation incorporated on July 17, 2001. WellPoint is a health benefits company in terms of commercial membership in the United States, 34.3 million medical members. The Company offers a spectrum of network-based managed care plans to the large and small employer, individual, Medicaid and senior markets. Its managed care plans include: preferred provider organizations, or PPOs; health maintenance organizations, or HMOs; point-of-service plans, or POS plans; traditional indemnity plans and other hybrid plans, including consumer-driven health plans, or CDHPs; and hospital only and limited benefit products. In addition, The Company provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. It also provides an array of specialty products and services including life and disability insurance benefits, dental, vision, behavioral health benefit services, radiology benefit management, analytics-driven personal health care guidance and long-term care insurance. Finally, the Company provides services to the Federal Government in connection with the Federal Employee Program, or FEP, and various Medicare programs. The Company is licensed to conduct insurance operations in all 50 states through its subsidiaries. It is an independent licensee of the Blue Cross and Blue Shield Association, an association of independent health benefit plans. The Company manages its operations through three reportable segments: Commercial; Consumer; and Other. Commercial and Consumer segments both offer a mix of managed care products, including PPOs, HMOs, traditional indemnity benefits and POS plans, as well as a variety of hybrid benefit plans, including CDHPs, hospital only and limited benefit products. Commercial segment includes Local Group (including UniCare), National Accounts and certain other ancillary business operations (dental, vision, life and disability and workers' compensation). Business units in the Commercial segment offer fully-insured products and provide an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. Consumer segment includes Senior, State-Sponsored and Individual business. Senior business includes services such as Medicare Advantage (including private fee-for-service plans and special needs plans), Medicare Part D, and Medicare Supplement, while State-Sponsored business includes its managed care alternatives for Medicaid and State Children's Health Insurance Plan programs. Individual business includes individual customers under age 65 and their covered dependents. Other segment includ
Company Website
SEC Reports
Industry: Health Care Plans
Compare:UNH, ESRX, HUM, AET, CI
Traded in other countries:AE1.Germany

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial